Reina Sato

SerumHumanTelomerase ReverseTranscriptaseMessenger RNA as a NovelTumorMarker for Hepatocellular Carcinoma

T. Harada, J. Hasegawa, G. Shiota, 2005 .

Serum Human Telomerase Reverse Transcriptase Messenger RNA as a Novel Tumor Marker for Hepatocellular Carcinoma

N. Miura, T. Harada, J. Hasegawa, 2005, Clinical Cancer Research.

Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis

Y. Takikawa, Kazuyuki Suzuki, Hiroko Kabashima, 2008, Hepatology international.

Human RGM249-derived small RNAs potentially regulate tumor malignancy.

Y. Tabata, J. Jo, N. Miura, 2013, Nucleic acid therapeutics.

A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT

M. Oshimura, A. Gazdar, A. Virmani, 2009, BMC Molecular Biology.

Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer

Hisao Ito, K. Shomori, N. Miura, 2006, Cancer science.

A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.

J. Kigawa, Y. Kanamori, Masakuni Takahashi, 2007, Oncology reports.